🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
KYM
$KYMR
🔒 US EquitiesKymera Therapeutics Inc
AVG HISTORICAL GAP
+0.17%
MAX GAP RECORD
-12.64%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $KYMR
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$KYMR
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (UNDETERMINED) |
+0.00%
|
| Aug 05, 2026 Earnings Release 2026-08-05 (UNDETERMINED) |
+0.00%
|
| Apr 30, 2026 Earnings Release 2026-04-30 (BEFORE OPEN) |
+4.76%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN) |
-5.16%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN) |
-6.56%
|
| Aug 11, 2025 Earnings Release 2025-08-11 (BEFORE OPEN) |
-6.06%
|
| May 09, 2025 Earnings Release 2025-05-09 (BEFORE OPEN) |
+9.33%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN) |
-3.85%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
6.4%
Bullish Gaps (6)
Bearish Gaps (6)
Neutral / Flat (1)
📖 Intelligence Summary
Kymera Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of human diseases through the development of innovative, highly differentiated medicines. It focuses on discovering and developing novel small-molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s natural protein degradation system. The company leverages targeted…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗